Combined treatment with a pH-sensitive fusogenic peptide and cationic lipids achieves enhanced cytosolic delivery of exosomes

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Nakase, Ikuhiko ^a   Futaki, Shiroh ^b  

^a Osaka Prefecture University   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CATION; CD63 ANTIGEN; DEXTRAN; GALA PEPTIDE; LIPID; PEPTIDE; RIBOSOME INACTIVATING PROTEIN 1; SAPORIN;

AMINO ACID SEQUENCE; CHEMISTRY; CONFOCAL MICROSCOPY; CYTOSOL; ENDOCYTOSIS; EXOSOME; GENETICS; HELA CELL LINE; HUMAN; METABOLISM; MOLECULAR GENETICS; PH;

AMINO ACID SEQUENCE; ANTIGENS, CD63; CATIONS; CYTOSOL; DEXTRANS; ENDOCYTOSIS; EXOSOMES; HELA CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; LIPIDS; MICROSCOPY, CONFOCAL; MOLECULAR SEQUENCE DATA; PEPTIDES; RIBOSOME INACTIVATING PROTEINS, TYPE 1;

EID: 84930225125     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep10112     Document Type: Article

References (40)

1. Tan, A., Rajadas, J. & Seifalian, A. M. Exosomes as nano-theranostic delivery platforms for gene therapy. Adv. Drug Deliv. Rev. 65, 357-367 (2013).
2. Vlassov, A.V., Magdaleno, S., Setterquist, R. & Conrad, R. Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim. Biophys. Acta. 1820, 940-948 (2012).
3. van Dommelen, S.M. et al. Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery. J. Control Release 161, 635-644 (2012).
4. Conde-Vancells, J. et al. Characterization and comprehensive proteome profiling of exosomes secreted by hepatocytes. J. Proteome Res. 7, 5157-5166 (2008).
5. Subra, C. et al. Exosomes account for vesicle-mediated transcellular transport of activatable phospholipases and prostaglandins. J. Lipid Res. 51, 2105-2120 (2010).
6. Morelli, A. E. et al. Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. Blood 104, 3257-3266 (2004).
7. Théry, C., Ostrowski, M., & Segura, E. Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol. 9, 581-593 (2009).
8. Tian, T. et al. Visualizing of the cellular uptake and intracellular trafficking of exosomes by live-cell microscopy. J. Cell. Biochem. 111, 488-496 (2010).
9. Svensson, K.J. et al. Exosome uptake depends on ERK1/2-heat shock protein 27 signaling and lipid Raft-mediated endocytosis negatively regulated by caveolin-1. J. Biol. Chem. 288, 17713-17724 (2013).
10. Hannafon, B.N., Ding, & W.Q. Intercellular communication by exosome-derived microRNAs in cancer. Int. J. Mol. Sci. 14, 14240-14269 (2013).
11. Properzi, F., Logozzi, M., & Fais, S. Exosomes: the future of biomarkers in medicine. Biomark. Med. 7, 769-778 (2013).
12. Ogata-Kawata, H. et al. H.Circulating exosomal microRNAs as biomarkers of colon cancer. PLoS One 9, e92921 (2014).
13. Wahlgren, J. et al. Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes. Nucleic Acids Res. 40, e130 (2012).
14. Kosaka, N. et al. Exosomal tumour-suppressive microRNAs as novel cancer therapy: "exocure" is another choice for cancer treatment. Adv. Drug Deliv. Rev. 65, 376-382 (2013).
15. Brambilla, D., Luciani, P., & Leroux, J.C. Breakthrough discoveries in drug delivery technologies: the next 30 years. J. Control. Release 190, 9-14 (2014).
16. Alvarez-Erviti, L. et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat. Biotechnol. 29, 341-345 (2011).
17. Lai, R. C., Yeo, R. W., Tan, K. H. & Lim, S. K. Exosomes for drug delivery - a novel application for the mesenchymal stem cell. Biotechnol. Adv. 31, 543-551 (2013).
18. Tian, T. et al. Dynamics of exosome internalization and trafficking. J. Cell. Physiol. 228, 1487-1495 (2013).
19. Tian, Y. et al. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumour therapy. Biomaterials 35, 2383-2390 (2014).
20. Kobayashi, S. et al. Cytosolic targeting of macromolecules using a pH-dependent fusogenic peptide in combination with cationic liposomes. Bioconjug. Chem. 20, 953-959 (2009).
21. Nakase, I., Kogure, K., Harashima, H., & Futaki S. Application of a fusiogenic peptide GALA for intracellular delivery. Methods Mol. Biol. 683, 525-533 (2011).
22. Sokolova, V. et al. Characterisation of exosomes derived from human cells by nanoparticle tracking analysis and scanning electron microscopy. Colloids Surf. B Biointerfaces 87, 146-150 (2011).
23. Hood, J.L., San, R.S., & Wickline, S.A. Exosomes released by melanoma cells prepare sentinel lymph nodes for tumour metastasis. Cancer Res. 71, 3792-3801 (2011).
24. Takahashi, Y. et al. Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection. J. Biotechnol. 165, 77-84 (2013).
25. Hunt, M. A., Currie, M. J., Robinson, B. A., & Dachs, G. U. Optimizing transfection of primary human umbilical vein endothelial cells using commercially available chemical transfection reagents. J. Biomol. Tech. 21, 66-72 (2010).
26. Subbarao, N. K. et al. pH-dependent bilayer destabilization by an amphipathic peptide. Biochemistry 26, 2964-2972 (1987).
27. Li, W., Nicol, F., & Szoka, F. C. Jr. GALA: a designed synthetic pH-responsive amphipathic peptide with applications in drug and gene delivery. Adv. Drug Deliv. Rev. 56, 967-985 (2004).
28. Bostad M. et al. Light-triggered, efficient cytosolic release of IM7-saporin targeting the putative cancer stem cell marker CD44 by photochemical internalization. Mol. Pharm. 11, 2764-1776 (2014).
29. Parolini, I. et al. Microenvironmental pH is a key factor for exosome traffic in tumour cells. J. Biol. Chem. 284, 34211-34222 (2009).
30. Nakase, I., Kobayashi, S., & Futaki, S. Endosome-disruptive peptides for improving cytosolic delivery of bioactive macromolecules. Biopolymers 94, 763-770 (2010).
31. Simões, S. et al. Gene delivery by negatively charged ternary complexes of DNA, cationic liposomes and transferrin or fusigenic peptides. Gene Ther. 5, 955-964 (1998).
32. Simões, S. et al. Mechanisms of gene transfer mediated by lipoplexes associated with targeting ligands or pH-sensitive peptides. Gene Ther. 6, 1798-1807 (1999).
33. Simões, S. et al. Transfection of human macrophages by lipoplexes via the combined use of transferrin and pH-sensitive peptides. J. Leukoc. Biol. 65, 270-179 (1999).
34. Simões, S. et al. Human serum albumin enhances DNA transfection by lipoplexes and confers resistance to inhibition by serum. Biochim Biophys Acta. 1463, 459-469 (2000).
35. Futaki, S. et al. Unique features of a pH-sensitive fusogenic peptide that improves the transfection efficiency of cationic liposomes. J. Gene Med. 7, 1450-1458 (2005).
36. Nicol, F., Nir, S., Szoka, & F. C. Jr. Effect of cholesterol and charge on pore formation in bilayer vesicles by a pH-sensitive peptide. Biophys. J. 71, 3288-3301 (1996).
37. Nicol, F., Nir, S., Szoka, & F. C. Jr. Effect of phospholipid composition on an amphipathic peptide-mediated pore formation in bilayer vesicles. Biophys. J. 78, 818-829 (2000).
38. Choi, H. S., Huh, J., Jo, & W. H. pH-induced helix-coil transition of amphipathic polypeptide and its association with the lipid bilayer: electrostatic energy calculation. Biomacromolecules 7, 403-406 (2006).
39. Théry, C., Amigorena, S., Raposo, G. & Clayton, A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr. Protoc. Cell Biol. 30, Chapter 3, Unit 3.22 (2006).
40. Nakase, I. et al. Transformation of an antimicrobial peptide into a plasma membrane-permeable, mitochondria-targeted peptide via the substitution of lysine with arginine. Chem. Commun. 48, 11097-11099 (2012).